Tango Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TNGX Nasdaq 2830 www.tangotx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tango Therapeutics, Inc.

Tango Therapeutics (TNGX) Could Benefit From Pancreatic Ductal Adenocarcinoma Data Announcement - Jun 5th, 2026 9:55 am
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 5th, 2026 5:00 am
Here is Why Erasca (ERAS) is One of the Best Growth Stocks Under $20 - Jun 3rd, 2026 11:59 am
Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More - May 29th, 2026 6:41 pm
Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1 - May 26th, 2026 4:26 pm
A Look At Tango Therapeutics (TNGX) Valuation After Wider Losses And Boardroom Changes - May 21st, 2026 9:14 pm
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase - May 17th, 2026 2:46 pm
Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally - May 17th, 2026 2:17 pm
Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares - May 17th, 2026 2:07 pm
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy - May 16th, 2026 9:01 am
Tango Therapeutics (TNGX) Is Down 10.7% After Pipeline Pivot And Board Changes - Has The Bull Case Changed? - May 16th, 2026 8:10 am
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights - May 13th, 2026 2:07 pm
Stifel Remains Bullish on Tango Therapeutics (TNGX) - May 10th, 2026 5:13 pm
Why This CEO Is Confident His Drug Can Top 'Unprecedented' Pancreatic Cancer Results - Apr 30th, 2026 6:00 am
Does Erasca (ERAS) Expanding ERAS-0015 to China Recast Its Global Oncology Ambitions? - Apr 20th, 2026 12:06 pm
Is Tango Therapeutics (TNGX) Building the Right Leadership Mix to Navigate Complex Oncology Pipelines? - Apr 18th, 2026 5:04 pm
Erasca (ERAS) Climbs 390% YTD on ‘Best-in-Class’ Potential of Cancer Treatment - Apr 17th, 2026 5:39 am
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat - Apr 15th, 2026 7:05 am
Tango Therapeutics President Sells 27,000 Shares for $572,000 as Share Price Skyrockets - Apr 8th, 2026 8:12 am
Stifel and Jefferies Raise Targets on Tango Therapeutics (TNGX) - Apr 6th, 2026 3:10 pm